U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.572G>A (p.Arg191Gln) AND Maturity onset diabetes mellitus in young

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 31, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002347992.3

Allele description [Variation Report for NM_000162.5(GCK):c.572G>A (p.Arg191Gln)]

NM_000162.5(GCK):c.572G>A (p.Arg191Gln)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.572G>A (p.Arg191Gln)
Other names:
NM_000162.5(GCK):c.572G>A; p.Arg191Gln
HGVS:
  • NC_000007.14:g.44149976C>T
  • NG_008847.2:g.53195G>A
  • NM_000162.5:c.572G>AMANE SELECT
  • NM_001354800.1:c.572G>A
  • NM_033507.3:c.575G>A
  • NM_033508.3:c.569G>A
  • NP_000153.1:p.Arg191Gln
  • NP_001341729.1:p.Arg191Gln
  • NP_277042.1:p.Arg192Gln
  • NP_277043.1:p.Arg190Gln
  • LRG_1074t1:c.572G>A
  • LRG_1074t2:c.575G>A
  • LRG_1074:g.53195G>A
  • LRG_1074p1:p.Arg191Gln
  • LRG_1074p2:p.Arg192Gln
  • NC_000007.13:g.44189575C>T
  • NM_000162.3:c.572G>A
Protein change:
R190Q
Links:
dbSNP: rs886042610
NCBI 1000 Genomes Browser:
rs886042610
Molecular consequence:
  • NM_000162.5:c.572G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.572G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.575G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.569G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Maturity onset diabetes mellitus in young (MODY)
Synonyms:
Mason type diabetes
Identifiers:
MONDO: MONDO:0018911; MedGen: C0342276; Orphanet: 552; OMIM: 606391; Human Phenotype Ontology: HP:0004904

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002650655Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Oct 31, 2022)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI.

Massa O, Meschi F, Cuesta-Munoz A, Caumo A, Cerutti F, Toni S, Cherubini V, Guazzarotti L, Sulli N, Matschinsky FM, Lorini R, Iafusco D, Barbetti F; Diabetes Study Group of the Italian Society of Paediatic Endocrinology and Diabetes (SIEDP)..

Diabetologia. 2001 Jul;44(7):898-905.

PubMed [citation]
PMID:
11508276

Glucokinase mutations in young children with hyperglycemia.

Codner E, Deng L, Pérez-Bravo F, Román R, Lanzano P, Cassorla F, Chung WK.

Diabetes Metab Res Rev. 2006 Sep-Oct;22(5):348-55.

PubMed [citation]
PMID:
16444761
See all PubMed Citations (10)

Details of each submission

From Ambry Genetics, SCV002650655.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

The p.R191Q pathogenic mutation (also known as c.572G>A), located in coding exon 5 of the GCK gene, results from a G to A substitution at nucleotide position 572. The arginine at codon 191 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been described in the heterozygous state in several unrelated individuals with maturity-onset diabetes of the young (MODY), type 2 (Caetano LA et al. Arq Bras Endocrinol Metabol, 2012 Nov;56:519-24; Pruhova S et al. Pediatr Diabetes, 2010 Dec;11:529-35; Codner E et al. Pediatr Diabetes, 2009 Sep;10:382-8; Codner E et al. Diabetes Metab Res Rev;22:348-55; Fulcoli FG et al. Nat Commun, 2016 06;7:11688; Aykut A et al. Gene, 2018 Jan;641:186-189; Yorifuji T et al. Pediatr Diabetes, 2018 11;19:1164-1172; Massa O et al. Diabetologia, 2001 Jul;44:898-905; Li X et al. BMC Pediatr, 2018 03;18:101; Al-Kandari H et al. Sci Rep, 2021 08;11:16060). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is expected to be causative of maturity-onset diabetes of the young (MODY), type 2 and permanent neonatal diabetes; however, its clinical significance for GCK-related neonatal hyperinsulinemic hypoglycemia is unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024